Researchers say GlycoCaging may offer a route to rescue promising drug candidates that currently show unacceptable systemic ...

A new approach to drug design can deliver medicine directly to the gut in mice at significantly lower doses than current inflammatory bowel disease treatments. The proof-of-concept study, published ...

A new approach to drug design can deliver medicine directly to the gut in mice at significantly lower doses than current inflammatory bowel disease treatments. The proof-of-concept study ...

A cancer-causing protein long thought to be resistant to medication could soon be the target of new drugs ... so we can rationally design compounds or drug seeds that enter and stop the cancer ...